FDA Says It Sent Letters To 74 Manufacturers Of Opioid Analgesics Intended For Outpatient Use, Will Soon Issue Guidance For Applicants Seeking Approval For Generic Versions Of Abuse-Deterrent Opioids
Hal Lindon